North America Lymphedema Treatment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Lymphedema Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Lymphedema Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Lymphedema Treatment Market Regional Analysis

6.2 North America Lymphedema Treatment Market Revenue 2019-2028 (US$ Million)

6.3 North America Lymphedema Treatment Market Forecast Analysis

7. North America Lymphedema Treatment Market Analysis – by Condition Type

7.1 Primary Lymphedema and Secondary Lymphedema

7.1.1 Overview
7.1.2 Primary Lymphedema and Secondary Lymphedema: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Lymphedema Treatment Market Analysis – by Treatment Type

8.1 Laser Therapy

8.1.1 Overview
8.1.2 Laser Therapy: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Compression Devices and Bandaging

8.2.1 Overview
8.2.2 Compression Devices and Bandaging: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Drug Therapy

8.3.1 Overview
8.3.2 Drug Therapy: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Physiological Procedures

8.4.1 Overview
8.4.2 Physiological Procedures: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Debulking Procedures

8.5.1 Overview
8.5.2 Debulking Procedures: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.6 Others

8.6.1 Overview
8.6.2 Others: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Lymphedema Treatment Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Clinics: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Clinical Research Organizations

9.3.1 Overview
9.3.2 Clinical Research Organizations: North America Lymphedema Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Lymphedema Treatment Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Lymphedema Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Lymphedema Treatment Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Lymphedema Treatment Market Breakdown, by Condition Type
10.2.1.1.2 US: North America Lymphedema Treatment Market Breakdown, by Treatment Type
10.2.1.1.3 US: North America Lymphedema Treatment Market Breakdown, by End User

10.2.1.2 Canada: North America Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Lymphedema Treatment Market Breakdown, by Condition Type
10.2.1.2.2 Canada: North America Lymphedema Treatment Market Breakdown, by Treatment Type
10.2.1.2.3 Canada: North America Lymphedema Treatment Market Breakdown, by End User

10.2.1.3 Mexico : North America Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Lymphedema Treatment Market Breakdown, by Condition Type
10.2.1.3.2 Mexico : North America Lymphedema Treatment Market Breakdown, by Treatment Type
10.2.1.3.3 Mexico : North America Lymphedema Treatment Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 3M Company

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bio Compression Systems Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 BSN medical GmbH

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Huntleigh Healthcare Limited

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Lohmann & Rauscher GmbH & Co. KG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Mego Afek ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Sigvaris Group

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Smith & Nephew

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Tactile Medical

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 ThermoTek

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Lymphedema Treatment Market